In a report released yesterday, Lee Hambright from Bernstein maintained a Buy rating on Dexcom, with a price target of $84.00. The company’s shares closed yesterday at $66.96.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback